Fundz Deep Dive
Everything you need to win Panacea Biotec — in one platform.
Who to reach, what to say, and why now on Panacea Biotec — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Panacea Biotec — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Panacea Biotec Receives $14.95 Million Contract from UNICEF for Polio Vaccine Supply
Dec 26, 2024•over 1 year ago
Contract Type
contract
ManufacturingBiotechnologyPharmaceutical
Description
Panacea Biotec has been awarded a Letter Of Award (LoA) from UNICEF for the supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth approximately USD 14.95 million. The contract is set to be executed in the calendar year 2025 for the supply of bOPV to UNICEF for its requirements in countries in Africa and Asia.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months